ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Philip R. Belcher
Elijah W. Muriithi
David J. Wheatley
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaudhry, M. A.
Right arrow Articles by Wheatley, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaudhry, M. A.
Right arrow Articles by Wheatley, D. J.
Related Collections
Right arrow Myocardial protection

Ann Thorac Surg 2003;75:890-898
© 2003 The Society of Thoracic Surgeons

Original article: cardiovascular

Erythrocyte-containing versus crystalloid cardioplegia in the rat: effects on myocardial capillaries

Mubarak A. Chaudhry, FRCSa, Philip R. Belcher, MDa*, Stephen P. Day, MSa, Elijah W. Muriithi, MDa, David J. Wheatley, MDa

a Department of Cardiac Surgery, University of Glasgow, Royal Infirmary, Glasgow, United Kingdom

Accepted for publication October 1, 2002.

* Address reprint requests to Dr Belcher, Department of Cardiac Surgery, University of Glasgow, Royal Infirmary, 10 Alexandra Place, Glasgow, G31 2ER, UK
e-mail: pbelcher{at}clinmed.gla.ac.uk

BACKGROUND: The purpose of this study was to investigate the effects of crystalloid and erythrocyte-containing cardioplegia on capillary morphology of the isolated erythrocyte-perfused rat heart.

METHODS: Hearts from adult Sprague-Dawley rats were perfused throughout with resuspended sheep erythrocytes and subjected to the following protocols (n = 6, all groups): (1) 15 minutes nonworking and 30 minutes working heart mode (control; group 1); (2) as for group 1, with 30 minutes erythrocyte-containing (BL) or crystalloid (CR) cardioplegic arrest without reperfusion (groups 2BL and 2CR); (3) as for group 2, with 30 minutes nonworking reperfusion (groups 3BL and 3CR); and (4) as for group 3, with 30 minutes working heart mode (groups 4BL and 4CR). After each protocol troponin I from coronary effluent was measured. Corrosion casts were then made of the coronary microvasculature. Cast density was calculated as cast volume per left ventricular dry weight. Casts also underwent scanning electron microscopy. Analysis was by analysis of variance. Values are mean ± standard deviation.

RESULTS: Prearrest working heart coronary flow averaged 15.1 ± 4.7 mL/min without any differences among groups. Coronary flow in group 4 working hearts was the same before and after either cardioplegia. Cardiac outputs were similarly consistent in all groups. Cast density in group 1 (control) was 9.60 ± 1.17 x 10-2 mm3/mg. It was unaltered by erythrocyte-containing cardioplegia, but after crystalloid cardioplegia (group 2CR), it was 6.52 ± 0.93 x 10-2 mm3/mg (p = 0.0001 versus group 1 and p = 0.0007 versus group 2BL). With 30 minutes of nonworking reperfusion (group 3CR, there was slight improvement in cast density at 7.60 ± 0.90 x 10-2 mm3/mg (p = 0.0072 versus group 1; p = 0.0242 versus group 3BL). No further improvement was seen in group 4CR. Electron micrographs showed circumferential angularities or narrowings in crystalloid-perfused, arrested hearts, consistent with ischemic damage. Troponin I rose significantly after reperfusion in all groups, but it was higher in crystalloid-perfused, arrested hearts: 0.054 ± 0.013 µg/L versus 0.024 ± 0.017 µg/L (p = 0.0273).

CONCLUSIONS: Erythrocyte-containing cardioplegia maintained capillary density and morphology. Crystalloid cardioplegia produced capillary loss, visible abnormalities, and higher troponin I release. These hearts may be more vulnerable to myocardial damage during reperfusion than hearts perfused with erythrocyte-containing cardioplegic solution.




This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
Y. Durandy and S. Hulin
Intermittent warm blood cardioplegia in the surgical treatment of congenital heart disease: Clinical experience with 1400 cases
J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 241 - 246.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.